BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35450030)

  • 1. Lack of Association of rs12702634 in
    Higuchi T; Oka S; Furukawa H; Shimada K; Tohma S
    Biomark Insights; 2022; 17():11772719221091758. PubMed ID: 35450030
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Juge PA; Sparks JA; Gazal S; Ebstein E; Borie R; Debray MP; Kannengiesser C; McDermott GC; Cui J; Hayashi K; Doyle TJ; van Moorsel CHM; van der Vis JJ; Grutters JC; Knevel R; Heckert SL; Vasarmidi E; Antoniou KM; van der Helm van Mil AHM; Boileau C; Crestani B; Dieudé P
    Rheumatol Adv Pract; 2024; 8(2):rkae059. PubMed ID: 38854416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the
    Shirai Y; Honda S; Ikari K; Kanai M; Takeda Y; Kamatani Y; Morisaki T; Tanaka E; Kumanogoh A; Harigai M; Okada Y
    Ann Rheum Dis; 2020 Oct; 79(10):1305-1309. PubMed ID: 32737115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of a
    Higuchi T; Oka S; Furukawa H; Shimada K; Tsunoda S; Ito S; Okamoto A; Katayama M; Saisho K; Shinohara S; Matsui T; Migita K; Nagaoka S; Tohma S
    RMD Open; 2023 Jan; 9(1):. PubMed ID: 36717188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.
    Juge PA; Lee JS; Ebstein E; Furukawa H; Dobrinskikh E; Gazal S; Kannengiesser C; Ottaviani S; Oka S; Tohma S; Tsuchiya N; Rojas-Serrano J; González-Pérez MI; Mejía M; Buendía-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou K; van Moorsel CHM; van der Vis J; de Man YA; Grutters JC; Wang Y; Borie R; Wemeau-Stervinou L; Wallaert B; Flipo RM; Nunes H; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Marchand-Adam S; Frazier A; Richette P; Allanore Y; Sibilia J; Dromer C; Richez C; Schaeverbeke T; Lioté H; Thabut G; Nathan N; Amselem S; Soubrier M; Cottin V; Clément A; Deane K; Walts AD; Fingerlin T; Fischer A; Ryu JH; Matteson EL; Niewold TB; Assayag D; Gross A; Wolters P; Schwarz MI; Holers M; Solomon JJ; Doyle T; Rosas IO; Blauwendraat C; Nalls MA; Debray MP; Boileau C; Crestani B; Schwartz DA; Dieudé P
    N Engl J Med; 2018 Dec; 379(23):2209-2219. PubMed ID: 30345907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
    Qiu M; Jiang J; Nian X; Wang Y; Yu P; Song J; Zou S
    Respir Res; 2021 Oct; 22(1):264. PubMed ID: 34635095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis-related interstitial lung disease: a meta-analysis.
    Xie S; Li S; Chen B; Zhu Q; Xu L; Li F
    Clin Rheumatol; 2021 Nov; 40(11):4533-4543. PubMed ID: 34189672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the pattern of interstitial lung disease on mortality in rheumatoid arthritis: A systematic literature review and meta-analysis.
    Singh N; Varghese J; England BR; Solomon JJ; Michaud K; Mikuls TR; Healy HS; Kimpston EM; Schweizer ML
    Semin Arthritis Rheum; 2019 Dec; 49(3):358-365. PubMed ID: 31153706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors and radiological characteristics of rheumatoid arthritis-associated interstitial lung disease in a multi-ethnic Malaysian cohort.
    Ong SG; Ding HJ; Zuhanis AH; Aida AA; Norazizah IW
    Med J Malaysia; 2022 May; 77(3):292-299. PubMed ID: 35638484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibody Seropositivity and Risk for Interstitial Lung Disease in a Prospective Male-Predominant Rheumatoid Arthritis Cohort of U.S. Veterans.
    Natalini JG; Baker JF; Singh N; Mahajan TD; Roul P; Thiele GM; Sauer BC; Johnson CR; Kawut SM; Mikuls TR; England BR
    Ann Am Thorac Soc; 2021 Apr; 18(4):598-605. PubMed ID: 33026891
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of disease activity with acute exacerbation of interstitial lung disease during tocilizumab treatment in patients with rheumatoid arthritis: a retrospective, case-control study.
    Akiyama M; Kaneko Y; Yamaoka K; Kondo H; Takeuchi T
    Rheumatol Int; 2016 Jun; 36(6):881-9. PubMed ID: 27072347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet/Lymphocyte, Lymphocyte/Monocyte, and Neutrophil/Lymphocyte Ratios as Biomarkers in Patients with Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Chen Q; Chen DY; Xu XZ; Liu YY; Yin TT; Li D
    Med Sci Monit; 2019 Aug; 25():6474-6481. PubMed ID: 31462627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts.
    Kiely P; Busby AD; Nikiphorou E; Sullivan K; Walsh DA; Creamer P; Dixey J; Young A
    BMJ Open; 2019 May; 9(5):e028466. PubMed ID: 31061059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Metabolomic Profiling in Rheumatoid Arthritis Patients With Interstitial Lung Disease: A Case-Control Study.
    Furukawa H; Oka S; Shimada K; Okamoto A; Hashimoto A; Komiya A; Saisho K; Yoshikawa N; Katayama M; Matsui T; Fukui N; Migita K; Tohma S
    Front Med (Lausanne); 2020; 7():599794. PubMed ID: 33392224
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis.
    Oka S; Higuchi T; Furukawa H; Shimada K; Okamoto A; Hashimoto A; Komiya A; Saisho K; Yoshikawa N; Katayama M; Matsui T; Fukui N; Migita K; Tohma S
    BMC Musculoskelet Disord; 2022 Jan; 23(1):46. PubMed ID: 35027028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of a Single Nucleotide Variant in
    Higuchi T; Oka S; Furukawa H; Shimada K; Tsunoda S; Ito S; Okamoto A; Fujimori M; Nakamura T; Katayama M; Saisho K; Shinohara S; Matsui T; Migita K; Nagaoka S; Tohma S
    Genes (Basel); 2023 Nov; 14(11):. PubMed ID: 38003027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis.
    Rojas-Serrano J; Herrera-Bringas D; Pérez-Román DI; Pérez-Dorame R; Mateos-Toledo H; Mejía M
    Clin Rheumatol; 2017 Jul; 36(7):1493-1500. PubMed ID: 28585060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis.
    Yang JA; Lee JS; Park JK; Lee EB; Song YW; Lee EY
    Korean J Intern Med; 2019 Mar; 34(2):434-441. PubMed ID: 28352064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum KL-6, CA19-9, CA125 and CEA are Diagnostic Biomarkers for Rheumatoid Arthritis-Associated Interstitial Lung Disease in the Chinese Population.
    Zheng M; Lou A; Zhang H; Zhu S; Yang M; Lai W
    Rheumatol Ther; 2021 Mar; 8(1):517-527. PubMed ID: 33586127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial Lung Disease and its Associations in Rheumatoid Arthritis: Data from a District General Hospital in Sri Lanka.
    Wickrematilake G
    Clin Med Insights Arthritis Musculoskelet Disord; 2021; 14():11795441211028747. PubMed ID: 34262385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.